NovoCure Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	699.19	655.35	605.22	509.34	537.84	535.03
Revenue Growth	10.96%	8.28%	18.82%	-5.30%	0.53%	8.23%
Cost of Revenue	166.92	166.88	137.18	128.28	114.87	114.88
Gross Profit	532.27	488.47	468.04	381.06	422.97	420.15
Selling, General & Admin	461.95	417.73	428.89	390.87	306.41	263.18
Research & Development	224.72	224.54	209.65	223.06	206.09	201.3
Total Operating Expenses	686.67	642.27	638.54	613.93	512.5	464.49
Operating Income	-154.4	-153.8	-170.5	-232.87	-89.52	-44.33
Total Non-Operating Income (Expense)	1.71	17.55	39.33	41.13	-7.68	7.74
Pretax Income	-152.69	-136.25	-131.16	-191.74	-81.85	-52.08
Provision for Income Taxes	-4.12	-0.02	37.47	15.3	10.69	6.28
Net Income	-148.57	-136.23	-168.63	-207.04	-92.53	-58.35
Net Income to Common	-148.57	-136.23	-168.63	-207.04	-92.53	-58.35
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	114	111	108	106	105	104
Shares Outstanding (Diluted)	114	111	108	106	105	104
Shares Change	3.59%	3.37%	1.36%	1.65%	0.24%	-4.58%
EPS (Basic)	-1.30	-1.22	-1.56	-1.95	-0.88	-0.60
EPS (Diluted)	-1.30	-1.22	-1.56	-1.95	-0.88	-0.60
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-25.43	-75.68	-69.22	-100.43	9.43	58.59
Free Cash Flow Growth	-	-	-	-	-83.90%	-30.40%
Free Cash Flow Per Share	-0.22	-0.68	-0.64	-0.94	0.09	0.56
Gross Margin	76.13%	74.54%	77.33%	74.81%	78.64%	78.53%
Operating Margin	-22.08%	-23.47%	-28.17%	-45.72%	-16.64%	-8.29%
Profit Margin	-21.25%	-20.79%	-27.86%	-40.65%	-17.20%	-10.91%
FCF Margin	-3.64%	-11.55%	-11.44%	-19.72%	1.75%	10.95%
EBITDA	-138.08	-139.15	-159.26	-221.9	-78.9	-34.08
EBITDA Margin	-19.75%	-21.23%	-26.31%	-43.57%	-14.67%	-6.37%
EBIT	-154.4	-153.8	-170.5	-232.87	-89.52	-44.33
EBIT Margin	-22.08%	-23.47%	-28.17%	-45.72%	-16.64%	-8.29%
Effective Tax Rate	2.70%	0.02%	-28.56%	-7.98%	-13.06%	-12.05%

SEC Filings: 10-K · 10-Q